Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Biotherapeutics
 More »

  • Formulation and Stabilization of Biotherapeutics
    Cambridge AL UNITED STATES shortprograms.mit.edu/fsb
    7-22-2013
  • Improving Proteomics Approaches
    ... Krystyna Hohenauer, director of biotherapeutics development, life science & technology at PerkinElmer, explained a clear trend toward biotherapeutics and the need for rapid ...
    5-15-2013
  • Oncobiologics Finds Partner to Launch Biosimilars in U.S., China
    is an important step toward introducing affordable, high-quality biotherapeutics to China. ... biosimilars and new biotherapeutics focused on cancer, immuno-oncology, and immunology. ...
    5-8-2013
  • Testing for Residual Host Cell Protein & DNA
    ... numbered below 1000 that will include a validated test and associated reference standards for quantitation of residual E. coli and CHO genomic DNA in recombinant biotherapeutics. ...
    5-1-2013
  • OBT Joins Boehringer Ingelheim in Cancer Drug Collaboration
    Oxford BioTherapeutics (OBT) will develop new cancer drugs with Boehringer Ingelheim (BI) by identifying new antibody targets, then granting BI rights to develop and commercialize ...
    4-29-2013
  • GEN | Biolinks
    Biopharmaceuticals Aldevron Alethia Biotherapeutics Alexion Pharmaceuticals Alexza ... Elevation Pharmaceuticals Eleven Biotherapeutics Eli Lilly and Company EMD Millipore ...
  • Biosimilars: 10 Drugs to Watch
    ... LG Life Sciences: LBEC0101 completed Phase I trial in South Korea Mycenax Biotech: TuNEX in Phase III clinical trials in Japan and South Korea Protalix Biotherapeutics: PRX-106 in ...
    4-22-2013
  • Boosting Downstream Productivity
    ... These improvements drive efficiencies in manufacturing and quality operations, and enable a better cost of goods in the production of biotherapeutics," commented Gebski. POROS XS ...
    4-15-2013
  • Virus Removal
    The company works with virus filtration products, with its Planova virus removal filters having been used in the production of biotherapeutics for over 20 years. Designed for ...
    4-15-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    ... Elelyso(tm) (taliglucerase alfa) 2012 sales: $18 million 8 Marketer(s): Protalix BioTherapeutics and Pfizer Indication(s): Long-term enzyme replacement therapy for adults with a ...
    4-4-2013
  • Media's Role in Cell Culture Success
    ... Ken Ludwig, business director, bioprocess at Corning Life Sciences, estimates that approximately 20% of today's mammalian cell cultures for biotherapeutics are ADC-free, with a ...
    4-1-2013
  • Medicine: Getting Personal
    ... Smith and Nephew announces acquisition of bioactive woundcare company Healthpoint Biotherapeutics for $782 million in November. 5. Organogenesis' Gintuit cell therapy product for ...
    3-15-2013
  • Meeting the Bioassay Challenge
    ... Cell banks used for producing biotherapeutics are not the same as analytical cell banks used for testing biotherapeutics. The latter provide a continuous supply of viable cells to ...
    3-15-2013
  • The ABCs of Glycoproteins: How to Combine Analytics, Biology...
    points for this webinar include: Role of glycan analysis in characterizing modern biotherapeutics The principles of UPLC separations for glycan structures and reference resources ...
    3-15-2013
  • Sorrento Boosts Cancer Pipeline with Igdrasol Purchase
    ... sales in 2011. Established in 2006 and headquartered in San Diego, Sorrento focuses on developing biotherapeutics for cancer, inflammation, metabolic, and infectious diseases. ...
    3-7-2013

  • Journal Articles

  • Biocompatibility of Pooled Human Immunoglobulin (Gamunex 10%...
    Dennis P. Han, William J. O'Brien, Brian Higgins
    Journal of Ocular Pharmacology and Therapeutics
    Journal of Ocular Pharmacology and Therapeutics Abstract Purpose: Gamunex 10% (Talecris Biotherapeutics, Research Triangle Park, NC), a commercially available preparation of pooled ...
  • Large-Scale Adeno-Associated Viral Vector Production Using a...
    Nathalie Clément, David R. Knop, Barry J. Byrne
    Human Gene Therapy and Part B: Methods
    Continued progression toward flexible, scalable production techniques is a prerequisite to support human clinical evaluation of these novel biotherapeutics. This review examines ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll